Abstract
Background:Despite advancements in SSc management, ILD remains the primary cause of death. Treating extensive or progressive SSc-ILD is crucial, but early identification and predicting progression risk are challenging. Recognizing high-risk...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have